April 17, 2012
by RICHARD DOLINAR, MD As a treating physician who also serves as the Chairman of the Alliance for Safe Biologic Medicines (ASBM), I have been watching with great interest as the Food and Drug Administration (FDA) begins to unveil the approach it will take to bring “biosimilar” medications to the US. Biosimilars are attempts to […]
April 11, 2012
By Dr. Richard Dolinar Chairman of the Alliance for Safe Biologic Medicines (Published April 5, 2012) Excerpt: Recently, the FDA issued a series of draft guidance documents that outlined the approach the agency would take to make biosimilars available for patients in the U.S. While the guidance documents emphasized that the FDA was rightly focused […]
December 14, 2010
Where there’s medicine, there’s money.
December 14, 2010
Biologic drugs are often referred to as ”miracle drugs“ for good reason…
December 14, 2010
Biologic drugs are often referred to as ”miracle drugs“ for good reason…
November 15, 2010
Americans elected a new Congress on Nov. 2, but the voting booth wasn’t the only place where critical issues were at stake that day.
November 15, 2010
Americans elected a new Congress on Nov. 2, but the voting booth wasn’t the only place where critical issues were at stake that day.
